“Noora” vaccine receives emergency use license

TEHRAN – Noora coronavirus vaccine, developed and produced by Baqiyatallah University of Medical Sciences, affiliated with the Islamic Revolution Guards Corps (IRGC), has received an emergency use license.

Negotiations underway to export Razi Cov Pars vaccine

TEHRAN – A number of countries have requested to purchase the Iranian-made Cov Pars vaccine for COVID-19, and negotiations are underway to take the necessary measures for export, vice president for research and technology of Razi Vaccine and Serum Research Institute, said.

Cov Pars causes 9-12 months immunity to COVID-19

TEHRAN – Studies show that Cov Pars vaccine, developed by the Razi Vaccine and Serum Research Institute of Iran, makes immunity for 9-12 months against the coronavirus, Reza Bani-Hashemi, the director for research and development at the institute, said on Sunday.

COVIRAN vaccine to begin clinical trial on children aged 12-18

TEHRAN – COVIRAN BAREKAT vaccine received a license to start a clinical trial on children aged 12 to 18 by the next week, Minoo Mohraz, a member of the National Scientific Committee of COVID-19, has said.

Monthly COVID-19 vaccine output reaches 10m doses

TEHRAN – The domestic manufacturers of coronavirus vaccine have managed to increase their monthly production to 10 million doses, Seyed Heydar Mohammadi, an official with the Food and Drug Administration, has said.

Spikogen vaccine licensed for emergency use

TEHRAN – The Food and Drug Administration has issued an emergency permit for the Iranian-Australian Spikogen vaccine, IRNA reported on Thursday.

Fakhra vaccine enters third phase of human test

TEHRAN – The third phase of the Fakhra vaccine’s human trial started on Monday by being administrated to 40,000 volunteers, IRIB reported.

Pastu Covac vaccine approved for children under 18

TEHRAN – Pastu Covac, developed jointly by the Pasteur Institute of Iran and Cuba's Finlay Vaccine Institute, is the only homegrown vaccine that includes use in children aged under 18.

Cov Pars begins third phase of clinical studies

TEHRAN – “Razi Cov Pars” vaccine entered on Sunday the third phase of the human trial, being administrated to 40,000 people, IRIB reported.

IRCS denies sending coronavirus vaccines to Venezuela

TEHRAN – The Iranian Red Crescent Society (IRCS), has denied sending any shipment of COVID-19 vaccines from Iran to Venezuela.

More 200,000 doses of COVIRAN vaccine delivered

TEHRAN – Some 200,000 doses of COVIRAN BAREKAT vaccine have been recently delivered to the Ministry of Health for public vaccination, Hassan Jalili, the vaccine’s production manager, said on Sunday.

“Noora” vaccine successfully passing first phase of clinical trial

TEHRAN – “Noora" coronavirus vaccine, domestically made by Baqiyatallah University of Medical Sciences affiliated to the Islamic Revolution Guard Corps (IRGC), is successfully passing the first phase of the clinical trial.

Cov Pars to produce 1m doses of vaccine monthly

TEHRAN – One million doses of “Razi Cov Pars” vaccine will be produced each month as of the sixth calendar month Shahrivar (starting August 23), Mohammad-Hassan Fallah Mehrabadi, deputy head of the Razi Vaccine and Serum Research Institute has announced.

Pastu Covac is world’s only vaccine targeting several mutations: expert

TEHRAN – Pastu Covac coronavirus vaccine, developed jointly by the Pasteur Institute of Iran and Cuba's Finlay Vaccine Institute, is the only vaccine in the world that can fight several mutations simultaneously, Alireza Biglari, head of the Pasteur Institute, has said.

COVIRAN vaccine beats Delta variant

TEHRAN – COVIRAN BAREKAT coronavirus vaccine proved effective against Indian strain, Hojjat Niki-Maleki head of the information center of Headquarters for Executing the Order of the Imam twitted on Saturday.

Pastu Covac neutralizes new COVID-19 strains

TEHRAN – Preliminary results of studies show that the Pastu Covac coronavirus vaccine, developed by the Pasteur Institute of Iran, fights very well against new variants of South Africa and India, and in other words, neutralizes them, Alireza Biglari, head of the Pasteur Institute, has said.

Import of coronavirus vaccine to reach 13m doses

TEHRAN – Twenty shipments of COVID-19 vaccine have so far been imported into the country, and the volume will soon reach 13 million doses.

Tehran-Havana strategic cooperation on coronavirus vaccine production

TEHRAN – The long history of cooperation between Iran and Cuba in biotechnology has led to a strategic relationship to develop a COVID-19 vaccine to fight against the global pandemic.

Iran among few countries with all vaccine production platforms

TEHRAN – Iran is one of the few countries that has all vaccine production platforms, Mohammad Reza Shanehsaz, head of the Iranian Food and Drug Administration, has stated.

IRGC starts clinical trial of “Noora” coronavirus vaccine

TEHRAN – The Islamic Revolution Guard Corps (IRGC) started the first phase of the clinical trial of its domestically-made "Noora" coronavirus vaccine on Sunday, IRIB reported.

By Faranak Bakhtiari

National glory

Leader: I did not want to use non-Iranian vaccines, because we should respect this national honor.

TEHRAN – Leader of the Islamic Revolution Ayatollah Ali Khamenei received the first dose of the homegrown coronavirus vaccine (COVIRAN BAREKAT) on Friday, showing trust to domestic production and national capability.

Cov Pars to monthly produce 1m doses of vaccine

TEHRAN – One million doses of “Razi Cov Pars” vaccine will be produced each month as of September, deputy head of the Razi Vaccine and Serum Research Institute has announced.

COVIRAN vaccine receives public use license

TEHRAN – Homegrown COVIRAN BAREKAT vaccine has received the license for public use, Health Minister Saeed Namaki announced on Monday.

Fakhra vaccine begins second human trial

TEHRAN – The second phase of the Fakhra vaccine’s human trial started on Wednesday by being administrated to 500 volunteers.

COVIRAN vaccine closer to completing human trials

TEHRAN – Eight thousand volunteers in four cities will receive the first dose of the COVIRAN vaccine on June 10, moving toward completing the third phase of human testing.

COVID-19 inoculation to rollout by homegrown vaccine this week

TEHRAN – Health Minister Saeed Namaki announced that immunization against coronavirus by the domestic vaccine (COVIRAN BAREKAT) will start by the next week, ISNA reported on Monday.

Iran-Cuba vaccine to complete clinical trials by mid-June

TEHRAN – Soberana-02 COVID-19 vaccine jointly developed by Iran and Cuba will complete clinical trials by mid-June by being administered to 24,000 Iranians.

Razi Cov Pars enters second clinical trial phase

TEHRAN – The second Iranian-made coronavirus vaccine, named Razi Cov Pars, started the second phase of the human trial on Friday by being administrated to 500 people.

No COVID-19 vaccine export until domestic need is met

TEHRAN – No homegrown COVID-19 vaccine will be exported until the domestic need is fully met, although several countries have asked for purchasing the COVIRAN BAREKAT vaccine, Mohammad Mokhber, the head of the Headquarters for Executing the Order of the Imam, has said.